Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News  >  Companies  >  All News

News : Companies

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

Global Ventricular Arrhythmia API Manufacturers, Marketed and Phase III Drugs Landscape Report 2017-2018 - Research and Markets

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/17/2017 | 07:52pm CEST

Research and Markets has announced the addition of the "Ventricular Arrhythmia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" drug pipelines to their offering.

Ventricular Arrhythmia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe.

A key objective of the Ventricular Arrhythmia Report is to understand the market and pipeline status of the drugs around the Ventricular Arrhythmia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline strategies. The Report provides the historical and forecasted sales of the drugs till 2018.

The Ventricular Arrhythmia Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Ventricular Arrhythmia.

While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Key Topics Covered:

1. Indication Overview

2. Market Drugs Landscape

3. Global API Manufacturers Assessment

4. Phase III Drugs Landscape

5. Drugs Market Data and Forecasted Sales Figure-2018

6. Marketed Drugs for Ventricular Arrhythmia

7. Phase III Drugs for Ventricular Arrhythmia

8. Discontinued Drugs for Ventricular Arrhythmia

9. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/cs9gkq/ventricular


© Business Wire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news "Companies"
02:54p MAGNETAR CAPITAL PARTNERS LP : - Form 8.3 - Berendsen Plc
02:54p Automatic Espresso Machines Market in North America to Grow at a CAGR of 6.8%, 2017-2021 with Breville, De'Longhi Appliances, GAGGIA & Nestl Nespresso Dominating - Research and Markets
02:53p SPARTAN MOTORS : Summary ToggleSpartan Motors to Attend Seaport Global Industrials and Coatings Conference on August 23
02:53p CELLAVISION : Global Test A – 2017
02:53p PATTERSON : Dental Announces Agreement with 3Shape to Distribute the Company's TRIOS Line of Intraoral Scanners and CAD Software for Dental Practices
02:53p Inca One Gold Announces 109% Increase in YOY Gold Production, Electrical Update and Changes to Board & Management
02:52p BERKWOOD RESOURCES : IIROC Trading Resumption - BKR
02:51p Malls must evolve to attract business
02:51p What's news
02:51p COMAC sets up major investments for future
Latest news "Companies"
Advertisement